Dr. Brian Conway, MD, FRCPC, is an infectious diseases specialist. He leads the Vancouver Infectious Diseases Centre, specializing in the design and evaluation of care systems for vulnerable inner-city residents, especially those living with HCV and HIV infection. He has led and published many seminal clinical trials in this field.

Dr. Adi Azahar N, a Doctor of Public Health candidate and trained medical officer, has served in rural Borneo and urban Kuala Lumpur, gaining diverse public health experience. Passionate about harm reduction, infectious diseases, and implementation science, his research focuses on hepatitis C treatment for PWUD and advancing community-based interventions.

MBBS, MD Microbiology working as Scientist C in the Hepatitis Group of ICMR-NIV Pune. Area of reasearch: HCV in intravenous drug users, cardiovascular risk in HCV infection, acute hepatitis of unknown origin (AHUO), CRISPR-based production of knock-out cell lines for HCV Undertaken outbreak investigations as part of National Central team

Camelia Capraru is the Executive Director of the Viral Hepatitis Care Network (VIRCAN). Camelia received her Medical Degree from University of Medicine and Pharmacy of Iasi, Romania. Her interests are in development and implementation of models of care for viral hepatitis C elimination.